FDA Inspection
American Red CrossAmerican Red Cross – FDA Inspection, Sep 7, 2023
Record Details
This FDA Inspection record concerns American Red Cross, with an inspection on September 7, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 472a83a3-361f-476c-96b5-c952d7c72177
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1218837
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 640.25(a)Storage temps./agitation
- 21 CFR 640.25(a)Storage temps./agitation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of American Red Cross
8| Date | Classification | Office | Project area |
|---|---|---|---|
| December 9, 2025 | Not classified | Baltimore District Office | |
| May 21, 2021 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 15, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 8, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 29, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for American Red Cross
- FDA Inspection 1296298 - 2025-12-09
- FDA Inspection 1142901 - 2021-05-21
- FDA Inspection 1043734 - 2018-02-15
- FDA Inspection 954722 - 2015-12-08
- FDA Inspection 893507 - 2014-08-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.